ROX Medical Gets $40M Funding

San Clemente-based ROX Medical, a startup developing medical devices to treat hypertension, has raised $40M in a Series E funding, the company said this morning. The funding was led by Novartis Venture Fund and Apple Tree Partners and also included prior investors Versant Ventures and Domain Associates. ROX Medical, which is led by CEO Rodney Brenneman, develops a stent-like device placed between the artery and vein in the upper leg, which reduces blood pressure. David McIntyre and Sami Hamade of Apple Tree Partners and Steven Weinstein of Novartis Venture Fund all join the company's Board of Directors with the funding. More information »